Targeting deadly emphysema, Peninsula med device company seeks $86M IPO

The company has accumulated a deficit of $210 million over its 25 years, but it has a product on the market.

Source: bizjournals.com Health Care:Biotechnology headlines - February 28, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news